Gregory M. Weinhoff
Chief Financial Officer
Neurology
Axovant Sciences
Switzerland
Biography
Dr. Gregory M. Weinhoff has served as Chief Financial Officer of Axovant Sciences, Inc. since August 2015. He has more than 20 years of experience in healthcare finance and operations including as a venture capital investor, operating executive and board member with Audit Committee experience. Previously, he was a partner at CHL Medical Partners, where he focused on investments in start-up and early-stage companies across therapeutics, diagnostics, medical devices and healthcare services. He was the founding Chief Executive Officer of Amicus Therapeutics and was subsequently a member of the Audit Committee of the company’s board of directors. Earlier in his career, he was founding President of VaxInnate and President of Resolvyx. He also held positions in the healthcare groups at J.H. Whitney & Co. and Morgan Stanley & Co. He received an MD from Harvard Medical School, an MBA from Harvard Business School (Baker Scholar), and an AB in economics (magna cum laude) from Harvard College.
Research Interest
neurology, healthcare, Therapeutics.
